IP Library Granted Patent US 8,329,416
Granted Patent B2
US 8,329,416 · App. 13/226,874 · Granted Dec 11, 2012

Stabilized standards for busulfan immunoassay

Assignee: Saladax Biomedical Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,329,416
App. No.
13/226,874
Granted
Dec 11, 2012
Kind
B2
Abstract

Use of busulfan amide as stabilized standards in immunoassays for quantifying the amount of busulfan in samples of human biological fluids, methods for carrying out said immunoassay and kits for use in said immunoassay.

Claims (11)

1. A kit for determining the amount of busulfan in a patient's sample by means of a busulfan immunoassay comprising a plurality of standards in separate containers, each of the standards containing a different predetermined concentration or amount of an amide of the formula:

and being packaged in separate containers and reagents for carrying out said busulfan immunoassay, said reagents being packaged in containers separate from those of said standards, wherein said reagents for carrying out said immunoassay comprise two separate containers, one of which containing an antibody which is selectively reactive with busulfan and not substantially cross-reactive with tetramethylene and tetrahydrothiophene-3-ol-1,1-dioxide and the other reagent being a conjugate of a polyamine polymer with a compound of the formula:

wherein A is lower alkylene;

X′ is a functional linking group;

Y is an organic spacing group;

X is a terminal functional group capable of binding to said polyamine polymer;

p and z are independent integers from 0 to 1;

or a compound of the formula

wherein A′ is lower alkyl or lower alkenylene.

2. The kit of claim 1 wherein said plurality of standards are in a number of at least three sufficient to generate a curve or a straight line by plotting the measured results obtained from said immunoassay of said standards against the concentration of said amide said standards.

3. The kit of claim 2 wherein each of the standards contains the amide of formula II in an inert liquid medium and the concentration of said amide in each of said standards is in the range of from 0 to 16,000 ng/ml.

Assignments (1)
SECURITY INTEREST Recorded Nov 17, 2015
From: SALADAX BIOMEDICAL, INC.
To: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Reel/Frame 037126/0733 →
Continuity (2)
Division 12212160 · Sep 17, 2008
Related Publication 20120225443A1 · Sep 6, 2012